Cargando…
Circulating CCL20 as a New Biomarker of Abdominal Aortic Aneurysm
Autoimmunity appears to play a role in abdominal aortic aneurysm (AAA) pathology. Although the chemokine CCL20 has been involved in autoimmune diseases, its relationship with the pathogenesis of AAA is unclear. We investigated CCL20 expression in AAA and evaluated it as a potential biomarker for AAA...
Autores principales: | Soto, B., Gallastegi-Mozos, T., Rodríguez, C., Martínez-González, J., Escudero, J.-R., Vila, L., Camacho, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725593/ https://www.ncbi.nlm.nih.gov/pubmed/29229985 http://dx.doi.org/10.1038/s41598-017-17594-6 |
Ejemplares similares
-
Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm
por: Solà-Villà, David, et al.
Publicado: (2015) -
Circulating Biomarkers for the Prediction of Abdominal Aortic Aneurysm Growth
por: Nana, Petroula, et al.
Publicado: (2021) -
Circulating biomarkers of cardiovascular disease are related to aneurysm volume in abdominal aortic aneurysm
por: Bouwens, Elke, et al.
Publicado: (2023) -
Oxidative Stress and Inflammatory Markers in Abdominal Aortic Aneurysm
por: Sánchez-Infantes, David, et al.
Publicado: (2021) -
Novel pharmacological approaches in abdominal aortic aneurysm
por: Puertas-Umbert, Lídia, et al.
Publicado: (2023)